div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: · P-selectin on venous thromboembolism in cancer patients with adenocarcinoma 2014 ASCO Annual Meeting abstr e 22049 B4 Tolerability of capecitabine in … src=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: · P-selectin on venous thromboembolism in cancer patients with adenocarcinoma 2014 ASCO Annual Meeting abstr e 22049 B4 Tolerability of capecitabine in … src=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: · P-selectin on venous thromboembolism in cancer patients with adenocarcinoma 2014 ASCO Annual Meeting abstr e 22049 B4 Tolerability of capecitabine in … src=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader042fdocumentsusreader042viewer20220315105cb87d3388c99358338b6378html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: · P-selectin on venous thromboembolism in cancer patients with adenocarcinoma 2014 ASCO Annual Meeting abstr e 22049 B4 Tolerability of capecitabine in …...